$30.03
0.27%
Nasdaq, Oct 02, 04:10 pm EDT. Closed.
ISIN
US8629453007
Symbol
ASST

Strive Inc Class A Stock price

$30.03
+5.71 23.48% 1M
+20.28 208.00% 6M
+15.27 103.46% YTD
-23.17 43.55% 1Y
-18.77 38.46% 3Y
-324.97 91.54% 5Y
-324.97 91.54% 10Y
-324.97 91.54% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
-0.08 0.27%
ISIN
US8629453007
Symbol
ASST

Is Strive Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$2.9b
Enterprise Value
$2.7b
Net debt
positive
Cash
$188.3m
Shares outstanding
81.9m
Valuation
P/E
negative
P/S | estimate
344.8 | 244.2
EV/Sales | estimate
322.7 | 228.5
EV/FCF | ex SBC
negative | negative
P/B
2.2
Financial Health
Equity Ratio
98.1%
Return on Equity
-58.1%
ROCE
-58.7%
ROIC
-67.7%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$32.9m | 386.6%
SBC as % of FCF
-
SBC Growth 1Y
2,033.8%
Share Count Growth 1Y
4,503.4%
Shareholder Yield
-4,503.4%
Financials
Revenue | estimate
$8.5m | $12.0m
EBITDA
$-793.3m
EBIT
$-793.6m
Net Income
$-975.5m
Free Cash Flow | ex SBC
$-79.5m | $-112.4m
Growth
Revenue | estimate
1,018.4% | 109.5%
EBITDA
-10,284.0%
EBIT
-10,287.8%
Net Income
-12,634.5%
Free Cash Flow
-1,221.3%
Margin
Gross
-
EBITDA
-9,332.3%
EBIT
-9,335.7%
Net
-11,474.6%
Free Cash Flow | ex SBC
-935.6% | -1,322.1%
More
EPS
$-13.0
FCF per Share
$-1.0
Short interest
28.3%
Employees
9
Rev per Employee
$640.0k

Strive Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Strive Inc Class A forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Strive Inc Class A forecast:

Buy
91%
Hold
9%

Financial data from Strive Inc Class A

Jun '26
+/-
%
8.50 8.50
1,018% 1,018%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 84 84
894% 894%
983%
- Research and Development Expense - -
-
-
-793 -793
10,284% 10,284%
-9,333%
- Depreciation and Amortization 0.29 0.29
-
3%
EBIT (Operating Income) EBIT -794 -794
10,288% 10,288%
-9,337%
Net Profit -975 -975
12,634% 12,634%
-11,476%

In millions USD.

Don't miss a Thing! We will send you all news about Strive Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Strive Inc Class A Stock News

Positive
Invezz
●
2 days ago
Top Bitcoin treasury stocks are on the verge of a strong bullish breakout as the coin rebounds. Strategy (MSTR) jumped to $160.50, up by over 102% from its lowest level this year.
Neutral
Business Wire
●
16 days ago
MIAMI--(BUSINESS WIRE)--REX Shares ("REX") and Tuttle Capital Management ("TCM") today announce the launch of the T-REX 2X Long ASST Daily Target ETF (Cboe: ASSX), a leveraged ETF providing 2x daily long exposure to Strive, Inc. (Nasdaq: ASST). ASSX is now listed and trading on Cboe. Fund name T-REX 2X Long ASST Daily Target ETF Fund ticker ASSX Exchange Cboe Underlying Strive, Inc. (Nasdaq: AS...
Neutral
GlobeNewsWire
●
about 2 months ago
DALLAS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced its financial results for the second quarter ended June 30, 2026. Key Highlights: Acquired a total of 6,236 bitcoin during the second quarter ended June 30, 2026 and 12,237 bitcoin during the six months ended June 30, 2026.
More Strive Inc Class A News

Company Profile

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. The company is headquartered in Dallas, Texas and currently employs 28 full-time employees. The company went IPO on 2023-02-03. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Head office United States
CEO Mr. Cole
Employees 9
Website investors.strive.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today